#United States #healthcare #Veeva Systems #Pleasanton #AI Agents

Veeva AI Agents Set for Comprehensive Launch

Veeva Systems, headquartered in Pleasanton, California, is set to implement Veeva AI agents across its application ecosystem. This initiative targets key areas including Commercial operations, R&D, and Quality. Starting in December 2025, the AI agents will enhance efficiency and innovation within these sectors, marking a significant technological advancement for the company.

Veeva's Vision for AI in Healthcare

Peter Gassner, CEO of Veeva, articulates a transformative vision for the pharmaceuticals industry, stating, "AI will fundamentally change how drugs are developed and treatment decisions are made in clinical settings." The introduction of Veeva AI seeks to accelerate drug delivery to patients by enhancing productivity and innovation in the industry.

The rollout timeline is well-structured, commencing with Veeva Vault CRM and PromoMats in December 2025, then progressing to Safety and Quality in April 2026, followed by Clinical Operations, Regulatory, and Medical in August 2026, and finally Clinical Data by December 2026.

Features of Veeva AI Agents

Veeva AI integrates deep learning capabilities tailored to the specific needs of healthcare applications. Each Veeva AI agent is designed to understand user context and includes application-specific prompts and safeguards. This means that users can interact safely with the data, documents, and workflows inherent to Veeva applications.

Additionally, Veeva's AI infrastructure utilizes Amazon's large language models (LLMs), hosted on Amazon Bedrock. This ensures robust performance and scalability, tailoring the capabilities to meet customer needs. Each custom agent created can leverage either Veeva-hosted models or customer-provided models hosted on platforms like Amazon Bedrock and Microsoft Azure AI Foundry.

Flexible Pricing Model

The pricing structure for Veeva AI is consumption-based, allowing clients to initiate the service easily and scale it as needed. This model is particularly beneficial for companies at various stages of growth, as it facilitates the adoption of cutting-edge technology without the burden of heavy initial investment.

Commitment to Stakeholders

Beyond technological innovation, Veeva remains committed to balancing the interests of all stakeholders. With a service history that spans over 1,500 companies—from leading biopharmaceutical giants to startups in the biotech field—Veeva aims to improve outcomes for patients globally. This drive for excellence underpins Veeva's vision and services in life sciences.

To stay updated with the latest developments on Veeva AI, you can follow the Veeva AI community on Veeva Connect and connect with the company on LinkedIn at Veeva Japan LinkedIn.

In summary, Veeva Systems is poised to revolutionize healthcare applications with the launch of Veeva AI agents, empowering the pharmaceutical industry to innovate and improve the delivery of medicines to broader populations efficiently. This ambitious project not only emphasizes the potential of AI in healthcare but also solidifies Veeva's leadership in the industry.

For corporate disclosures and updates, you can review Veeva's official site.